aortic pseudoaneurysm
Recently Published Documents


TOTAL DOCUMENTS

513
(FIVE YEARS 124)

H-INDEX

18
(FIVE YEARS 2)

2022 ◽  
Vol 2022 ◽  
pp. 1-4
Author(s):  
Sean-Tee J. M. Lim ◽  
Stephen Murphy ◽  
Said Atyani ◽  
Michael Anthony Moloney

A 47-year-old female presented to the emergency department with new episodes of hematemesis. She had a background of unresectable T4b + N1 + M0 esophageal squamous cell carcinoma. Contrast CT thoracic aorta diagnosed a ruptured mycotic aortic pseudoaneurysm of the descending aorta, forming a life threating aorto-esophageal fistula secondary to neoplasm. Due to the high risk of fatal haemorrhage, she underwent successful emergency thoracic endovascular aortic repair (TEVAR). Mycotic aortic pseudoaneurysms are a rare and often fatal complication of esophageal carcinomas. They represent a small subsection of aorto-esophageal fistulas. Early diagnosis with cross sectional imaging and vascular control of the sentinel bleed is essential for survival. TEVAR may be used as a bridge to palliative treatment in the case of unresectable esophageal carcinoma.


Cureus ◽  
2021 ◽  
Author(s):  
Anthony Lyonga Ngonge ◽  
Nitheesha Ganta ◽  
Abdelawab Jalal Eldin ◽  
Valery Effoe ◽  
Nso Nso ◽  
...  

Author(s):  
Aaron Clark ◽  
David Drullinsky ◽  
Suraj Parulkar ◽  
Christopher Mehta K

A 53 year old male with a history of vascular ring repair secondary to a right sided aortic arch with retroesophageal subclavian artery and ligamentum arteriosum to the descending thoracic aorta presented to our institution with a large aortic pseudoaneurysm of the distal aortic arch. Computed tomography demonstrated a right sided aortic arch with a 5.8 cm pseudoaneurysm arising from the distal arch in the area of his previously divided ligamentum. The patient underwent a successful two-stage repair including a left carotid to subclavian bypass followed by total arch replacement with frozen elephant trunk. He recovered well postoperatively and computed tomography showed complete repair of the pseudoaneurysm with patent bypass graft.


Vascular ◽  
2021 ◽  
pp. 170853812110630
Author(s):  
Lingwei Zou ◽  
Hao Liu ◽  
Xiaolang Jiang ◽  
Bin Chen ◽  
Junhao Jiang ◽  
...  

Objectives Behçet’s disease (BD) is a multisystem inflammatory disorder with unknown etiology, and its aneurysmal lesions are associated with high mortality due to the high risk of rupture. This study intended to further explore the long-term safety and efficacy of endovascular therapy for BD-related aortic pseudoaneurysm (BAP). Methods From January 2009 to May 2021, 17 BAP patients who underwent endovascular repair were retrospectively identified and enrolled. Adequate immunosuppressive treatment was instituted before and after endovascular treatment unless emergency surgery was required. The patients were followed up at 3, 6, and 12 months and yearly after the primary endovascular intervention by computed tomography angiography (CTA) examination. Results Nineteen BAPs were identified among 17 patients. BAPs located at the aortic arch were found in three patients (17.6%), descending thoracic aorta in 5 (29.4%), and abdominal aorta in 10 (58.8%; suprarenal abdominal aorta in 2 [11.8%], and infrarenal abdominal aorta in 8 [47.1%]). The mean ESR during admission was 56.5 ± 24.9 mm/h (range = 30.0–120.0 mm/h), which fell to 22.7 ± 18.4 mm/h (range = 2.0–74.0 mm/h) before the endovascular intervention ( p < 0.001). The rate of favorable immunosuppressive control before intervention is 76.5% (13/17). Technical success was achieved in all patients. Median follow-up time was 57.0 months (interquartile range [IQR] = 21.3–67.3 months). Pseudoaneurysm recurrence was observed in four patients, type I endoleak in one, pseudoaneurysms sac dilation in one, and external iliac artery occlusion in 1. Two patients died of pseudoaneurysm rupture. Five-year accumulated overall rate, recurrence-free rate, and reintervention-free survival rate of BAP patients were 92.8%, 75.4%, and 71.8%, respectively. Conclusion Endovascular treatment in BAP patients seemed to be associated with long-term safety and efficacy with a 5-year overall survival rate of 92.8%. Adequate immunosuppressive treatment was essential for BAP patients to prevent aortic pseudoaneurysm recurrence and improve the prognosis.


2021 ◽  
Vol 32 (12) ◽  
pp. 1708-1709
Author(s):  
Niraj Nirmal Pandey ◽  
Sanjeev Kumar ◽  
Amit Ajit Deshpande ◽  
Mansi Verma ◽  
Rishabh Khurana ◽  
...  

2021 ◽  
pp. 1-3
Author(s):  
Mustafa Yilmaz ◽  
Ata Niyazi Ecevit ◽  
Atakan Atalay

Abstract Pseudoaneurysms of the ascending aorta are rarely seen in paediatric patients. They may occur following complex cardiovascular surgery and are associated with a high risk of mortality due to their nature of spontaneous rupture. In this case report, we discuss a 1-year-old paediatric patient with an ascending aortic pseudoaneurysm following Norwood Stage 1 surgery with Sano modification for hypoplastic left heart syndrome and the patient’s successful recovery following aneurysmectomy with Norwood Stage 2 operation.


Author(s):  
Shanti Narayanasamy ◽  
Adam R Williams ◽  
Wiley A Schell ◽  
Rebekah W Moehring ◽  
Barbara D Alexander ◽  
...  

Abstract We report the first case of Curvularia alcornii aortic pseudoaneurysm following bioprosthetic aortic valve replacement in an immunocompetent host. Infection was complicated by septic emboli to multiple organs. Despite aggressive surgical intervention and antifungal therapy, infection progressed. We review the literature on invasive Curvularia infection to inform diagnosis and management.


2021 ◽  
Vol 3 (14) ◽  
pp. 1586-1588
Author(s):  
Anthony Matta ◽  
Nathanael Bayard ◽  
Paul Revel-Mouroz ◽  
Bertrand Marcheix ◽  
Frédéric Bouisset

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A76
Author(s):  
Steven Young ◽  
Anas Ahmed ◽  
Joy Wang ◽  
Mark Saling

Sign in / Sign up

Export Citation Format

Share Document